tiprankstipranks
Serina Therapeutics (SER)
:SER
US Market

Serina Therapeutics (SER) Financial Statements

Compare
193 Followers

Serina Therapeutics Financial Overview

Serina Therapeutics's market cap is currently $43.13M. The company's EPS TTM is $-5.941; its P/E ratio is ―; Serina Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 142.00K$ 500.00K$ 3.04M$ 54.00K$ 1.73M
Gross Profit$ -29.00K$ 355.00K$ 2.89M$ -1.23M$ 729.50K
Operating Income$ -9.96M$ -2.27M$ -1.63M$ -10.41M$ -12.56M
EBITDA$ -9.78M$ -2.60M$ -1.59M$ -8.74M$ -11.61M
Net Income$ -14.80M$ -2.68M$ -1.26M$ -10.87M$ -12.15M
Balance Sheet
Cash & Short-Term Investments$ 345.00K$ 532.23K$ 1.31M$ 527.00K$ 2.35M
Total Assets$ 11.96M$ 858.04K$ 1.84M$ 3.92M$ 7.44M
Total Debt$ 4.37M$ 1.81M$ 398.17K$ 6.30M$ 1.96M
Net Debt$ 4.02M$ 1.28M$ 83.33K$ 5.77M$ -396.00K
Total Liabilities$ 6.61M$ 38.64M$ 36.95M$ 9.32M$ 4.83M
Stockholders' Equity$ 5.47M$ -37.78M$ -35.11M$ -5.12M$ 2.22M
Cash Flow
Free Cash Flow$ -7.80M$ -2.09M$ -2.36M$ -7.84M$ -10.80M
Operating Cash Flow$ -7.80M$ -2.08M$ -2.25M$ -7.82M$ -10.16M
Investing Cash Flow$ -10.00M$ 980.94K$ 823.32K$ -20.00K$ -361.00K
Financing Cash Flow$ 17.50M$ 1.31M$ 1.08M$ 5.96M$ 6.26M
Currency in USD

Serina Therapeutics Earnings and Revenue History

Serina Therapeutics Debt to Assets

Serina Therapeutics Cash Flow

Serina Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis